The data is based on more than 2,000 children aged 12-15 years old who took part in trials of the Pfizer vaccine. There were no cases of Covid from a week after the second dose – compared to 16 cases in the placebo group, and the vaccine appeared to work as well in adolescents as in young adults aged 16-25.